{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:23Z","timestamp":1786997903227,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":721,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["AI079217"],"award-info":[{"award-number":["AI079217"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.virol.2011.06.029","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T23:31:19Z","timestamp":1314315079000},"page":"67-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies"],"prefix":"10.1016","volume":"418","author":[{"given":"Chungui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Crotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virol.2011.06.029_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2005.07.006","article-title":"Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene","volume":"341","author":"Aldaz-Carroll","year":"2005","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2011.06.029_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virol.2011.06.029_bb0015","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/JVI.02244-07","article-title":"Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine","volume":"82","author":"Benhnia","year":"2008","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2011.06.029_bb0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2011.06.029_bb0025","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","article-title":"Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles","volume":"80","author":"Chung","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.06.029_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0065-3527(06)66002-8","article-title":"In a nutshell: structure and assembly of the vaccinia virion","volume":"66","author":"Condit","year":"2006","journal-title":"Adv. Virus Res."},{"issue":"18","key":"10.1016\/j.virol.2011.06.029_bb0035","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2011.06.029_bb0040","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox","volume":"7","author":"Davies","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.virol.2011.06.029_bb0045","series-title":"Current Protocols in Molecular Biology","first-page":"16.17.1","article-title":"Generation of recombinant vaccinia viruses","author":"Earl","year":"1998"},{"issue":"16","key":"10.1016\/j.virol.2011.06.029_bb0050","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1128\/JVI.00568-08","article-title":"Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge","volume":"82","author":"Fogg","year":"2008","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2011.06.029_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, part II. Adverse events","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2011.06.029_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virol.2011.06.029_bb0065","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1086\/520936","article-title":"Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine-induced immunity","volume":"196","author":"He","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2011.06.029_bb0070","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/422999","article-title":"Clinical efficacy of intramuscular vaccinia immune globulin: a literature review","volume":"39","author":"Hopkins","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.virol.2011.06.029_bb0075","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2011.06.029_bb0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/viro.1996.0337","article-title":"Neutralizing epitope on penetration protein of vaccinia virus","volume":"220","author":"Ichihashi","year":"1996","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2011.06.029_bb0085","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1073\/pnas.89.2.628","article-title":"Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence","volume":"89","author":"Isaacs","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.virol.2011.06.029_bb0090","first-page":"149","article-title":"Membrane cell fusion activity of the vaccinia virus A17\u2013A27 protein complex","volume":"10","author":"Kochan","year":"2008","journal-title":"Cell. Microbiol."},{"issue":"52","key":"10.1016\/j.virol.2011.06.029_bb0095","doi-asserted-by":"crossref","first-page":"20711","DOI":"10.1073\/pnas.0809086106","article-title":"Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein","volume":"105","author":"Krumm","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.virol.2011.06.029_bb0100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1099\/vir.0.80660-0","article-title":"An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model","volume":"86","author":"Law","year":"2005","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2011.06.029_bb0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2004.07.024","article-title":"Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement","volume":"328","author":"Lustig","year":"2004","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.virol.2011.06.029_bb0110","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2011.06.029_bb0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3851\/IMP1573","article-title":"Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model","volume":"15","author":"McCausland","year":"2010","journal-title":"Antivir. Ther."},{"issue":"2","key":"10.1016\/j.virol.2011.06.029_bb0120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.virol.2007.10.023","article-title":"Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L","volume":"372","author":"Meng","year":"2008","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2011.06.029_bb0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.virol.2010.10.019","article-title":"Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus","volume":"409","author":"Meng","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.06.029_bb0130","series-title":"Fields Virology","first-page":"2905","article-title":"Poxviridae: the viruses and their replication","author":"Moss","year":"2007"},{"issue":"2","key":"10.1016\/j.virol.2011.06.029_bb0135","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2008.08.009","article-title":"Vaccinia virus entry\/fusion complex subunit A28 is a target of neutralizing and protective antibodies","volume":"380","author":"Nelson","year":"2008","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2011.06.029_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: an emerging zoonotic disease","volume":"2","author":"Parker","year":"2007","journal-title":"Future Microbiol."},{"issue":"11","key":"10.1016\/j.virol.2011.06.029_bb0145","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"Putz","year":"2006","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.virol.2011.06.029_bb0150","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/jvi.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodriguez","year":"1985","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2011.06.029_bb0155","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1128\/jvi.69.8.4640-4648.1995","article-title":"Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis","volume":"69","author":"Rodriguez","year":"1995","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2011.06.029_bb0160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","article-title":"Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen","volume":"355","author":"Sakhatskyy","year":"2006","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.virol.2011.06.029_bb0165","doi-asserted-by":"crossref","first-page":"7404","DOI":"10.1128\/jvi.71.10.7404-7420.1997","article-title":"Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment","volume":"71","author":"Salmons","year":"1997","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virol.2011.06.029_bb0170","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"16","key":"10.1016\/j.virol.2011.06.029_bb0175","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1128\/JVI.78.16.8885-8901.2004","article-title":"Vaccinia virus morphogenesis: a13 phosphoprotein is required for assembly of mature virions","volume":"78","author":"Unger","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2011.06.029_bb0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/viro.2001.1131","article-title":"The A17L gene product of vaccinia virus is exposed on the surface of IMV","volume":"290","author":"Wallengren","year":"2001","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2011.06.029_bb0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.virol.2011.06.029_bb0190","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1073\/pnas.96.20.11537","article-title":"IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins","volume":"96","author":"Xiang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682211002996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682211002996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:12:27Z","timestamp":1758586347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682211002996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0042682211002996"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2011.06.029","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2011.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}